| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/09/2011 | US20110135771 Novel Ayurvedic Formulation Advocated for the Prevention and Management of Coronary Heart Disease |
| 06/09/2011 | US20110135770 Apples with high polyphenolic content |
| 06/09/2011 | US20110135745 Drink formula comprising fresh marine omega-3 oil and antioxidants |
| 06/09/2011 | US20110135738 Single dosage pharmaceutical formulation comprising eprosartan mesylate |
| 06/09/2011 | US20110135717 Composition for Prevention or Treatment of Hyperlipidemia, Fatty Liver or Obesity |
| 06/09/2011 | US20110135707 Polyhydroxyalkanoates for in vivo applications |
| 06/09/2011 | US20110135665 Methods for treating reperfusion injuries |
| 06/09/2011 | US20110135657 Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof |
| 06/09/2011 | US20110135652 Novel Use of Idbf |
| 06/09/2011 | US20110135650 Morpholinone compounds as factor ixa inhibitors |
| 06/09/2011 | US20110135632 Methods for the modulation of angiogenesis |
| 06/09/2011 | US20110135595 Neuregulin based methods and compositions for treating cardiovascular disease |
| 06/09/2011 | US20110135580 Novel Medicament Combinations for the Treatment of Respiratory Diseases |
| 06/09/2011 | CA2782727A1 2-pyridone compounds |
| 06/09/2011 | CA2782691A1 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| 06/09/2011 | CA2781309A1 Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema |
| 06/08/2011 | EP2330213A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/08/2011 | EP2330193A1 Improved antibody molecule |
| 06/08/2011 | EP2330192A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 06/08/2011 | EP2330127A2 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same |
| 06/08/2011 | EP2330103A1 Novel epigallocatechin gallate tetramer, and vascular endothelial function improver comprising same |
| 06/08/2011 | EP2330092A2 Medicament comprising steviol or isosteviol for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 06/08/2011 | EP2329842A2 Interleukin-1 inhibitors in the treatment of diseases |
| 06/08/2011 | EP2329829A2 Use of uridine in combination with choline for the treatment of memory disorders |
| 06/08/2011 | EP2329828A1 Tetracyclines for the treatment of ischaemia |
| 06/08/2011 | EP2329826A1 Tetracyclines for the treatment of multiple sclerosis |
| 06/08/2011 | EP2329825A1 Method and composition for treating peripheral vascular diseases |
| 06/08/2011 | EP2329820A1 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 06/08/2011 | EP2329722A1 Populations of dairy cows producing milk with desirable characteristics and methods of making and using same |
| 06/08/2011 | EP2328897A1 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 06/08/2011 | EP2328892A1 Oxotetrahydrofuran-2-yl-benzimidazole derivative |
| 06/08/2011 | EP2328889A1 Acetyl pyrrolidinyl indole derivative |
| 06/08/2011 | EP2328879A2 Compounds, compositions and methods of using same for modulating uric acid levels |
| 06/08/2011 | EP2328873A2 Preparation of ranolazine |
| 06/08/2011 | EP2328869A2 Heteroaryl antagonists of prostaglandin d2 receptors |
| 06/08/2011 | EP2328863A1 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
| 06/08/2011 | EP2328599A2 Antihypertensive composition containing an extract of hymenocardia acida |
| 06/08/2011 | EP2328595A1 Methods for stimulating chondrogenesis utilizing a potassium channel inhibitor |
| 06/08/2011 | EP2328593A2 Cardioplegic preparation |
| 06/08/2011 | EP2328581A1 Use of dabigatranetexilate for treating patients with pulmonary hypertension |
| 06/08/2011 | EP2040691B1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoic acid |
| 06/08/2011 | EP1812426B1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 06/08/2011 | EP1431293B1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 06/08/2011 | EP1427427B1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/08/2011 | CN1965935B Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, formulation thereof, preparation method and application thereof |
| 06/08/2011 | CN1931287B Chinese medicine composition for treating piles and its preparation process |
| 06/08/2011 | CN1930155B Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
| 06/08/2011 | CN1919241B Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease |
| 06/08/2011 | CN1893979B Remedy for angitis |
| 06/08/2011 | CN1872213B Application of medication composition of containing peach kernel in preparing medication for treating chronic insufficiency of supplying blood for brain |
| 06/08/2011 | CN1872154B Application of medication composition of containing Yunnan red sage root in preparing medication for treating chronic insufficiency of supplying blood for brain |
| 06/08/2011 | CN1771978B Notoginseng triol-saponin composition and its preparation and use |
| 06/08/2011 | CN102089306A Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds |
| 06/08/2011 | CN102089305A Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido [3, 2, 1-iJ] quinoline compounds |
| 06/08/2011 | CN102089289A Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 06/08/2011 | CN102089277A Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 06/08/2011 | CN102089035A Maintenance of platelet inhibition during antiplatelet therapy |
| 06/08/2011 | CN102088993A Methods of treating inflammation |
| 06/08/2011 | CN102088978A Ameliorating or therapeutic agent for dyslipidemia |
| 06/08/2011 | CN102088961A Eprosartan compositions |
| 06/08/2011 | CN102086466A Almond functional hybrid peptide and preparation method thereof |
| 06/08/2011 | CN102086211A Aromatic heterocyclic compounds serving as protein kinase inhibitor |
| 06/08/2011 | CN102086195A Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof |
| 06/08/2011 | CN102086193A N-substituted alpha-amino acid derivatives and preparation method and application thereof |
| 06/08/2011 | CN102086182A Petasites tatewakianus Kitam. extract as well as preparation method and application thereof |
| 06/08/2011 | CN102086178A Cinepazide maleate disesquihydrate and preparation method thereof |
| 06/08/2011 | CN102085380A Preparation method of nano magnetic particles for detection and treatment of coronary heart diseases |
| 06/08/2011 | CN102085372A Application of Notch pathway inhibitor in treatment of tumors caused by activation of mTOR |
| 06/08/2011 | CN102085360A Medical composition with raw materials containing hirudin and application thereof |
| 06/08/2011 | CN102085359A Medical composition containing hirudin and hementerin and application thereof |
| 06/08/2011 | CN102085343A Traditional Chinese medicine composition for treating atrial fibrillation |
| 06/08/2011 | CN102085324A Traditional Chinese medicine composition for treating syndrome of disharmony between heart and kidney |
| 06/08/2011 | CN102085297A Traditional Chinese medicament for treating thrombus |
| 06/08/2011 | CN102085296A Drug for treating cerebral thrombosis |
| 06/08/2011 | CN102085295A Nano-emulsion pharmaceutical composition containing spring onion extract for oral mucosa administration and preparation method thereof |
| 06/08/2011 | CN102085288A Preparation method of traditional Chinese medicine compound preparation for improving hypertensive left ventricular hypertrophy |
| 06/08/2011 | CN102085287A Traditional Chinese medicine compound preparation for improving hypertensive left ventricular hypertrophy |
| 06/08/2011 | CN102085243A Medicament for treating diabetic foot |
| 06/08/2011 | CN102085230A Balloonflower dispersible tablets |
| 06/08/2011 | CN102085222A Method for preparing Shuxuening injection |
| 06/08/2011 | CN102085211A Water-soluble rutin solid dispersoid and preparation method thereof |
| 06/08/2011 | CN102085210A Medicinal composition for treating cerebral infarction |
| 06/08/2011 | CN102085208A Pharmaceutical composition for treating coronary heart disease and angina |
| 06/08/2011 | CN102085207A Medicinal composition |
| 06/08/2011 | CN102085206A Medicinal composition |
| 06/08/2011 | CN102085204A Pharmaceutical composition for resisting platelet aggregation |
| 06/08/2011 | CN102085201A Atenolol and amlodipine bilayer tablet |
| 06/08/2011 | CN102085195A Metoprolol succinate sustained-release tablets and preparation method thereof |
| 06/08/2011 | CN102085180A Dobutamine hydrochloride injection and preparation method thereof |
| 06/08/2011 | CN102085178A Production process for improving stability of enoxaparin sodium injection |
| 06/08/2011 | CN102085023A Nanometer Chinese medicine element anion far infrared electromagnetic wave pollution preventing and blood pressure reducing health care coat |
| 06/08/2011 | CN101810660B Water-soluble silymarin and preparation method thereof |
| 06/08/2011 | CN101757019B Medical composition for losing weight or treating metabolic syndromes |
| 06/08/2011 | CN101744821B Application of pentoxifylline in treatment of anorectal disease |
| 06/08/2011 | CN101716242B Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
| 06/08/2011 | CN101647797B Pharmaceutical composition containing Amlodipine besilate and valsartan and preparation method thereof |
| 06/08/2011 | CN101637457B Preparation method for cerebroprotein hydrolysate freeze-dried injection for injection |
| 06/08/2011 | CN101607069B Chinese traditional medicine for treating phlebitis, old lower extremity venous ulcer and venous purpura disease |